BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8901186)

  • 1. [SCE rate and lymphocyte differentiation in children with acute lymphoblastic leukemia and SCE rates of leukemia patients in long-term remission].
    Mertens R; Büssing A; Rubbert F; Lassay L; Heimann G
    Klin Padiatr; 1996; 208(2):73-6. PubMed ID: 8901186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood acute lymphoblastic leukemia (ALL): sister chromatid exchange (SCE) frequency and lymphocyte subpopulations during therapy.
    Mertens R; Rubbert F; Büssing A
    Leukemia; 1995 Mar; 9(3):501-5. PubMed ID: 7885047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Increased rate of sister chromatid exchange following therapy of acute lymphoblastic leukemias and non-Hodgkin lymphomas in childhood].
    Mertens R; Weidmann B; Habedank M
    Klin Padiatr; 1985; 197(4):273-6. PubMed ID: 3862912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recurrence of acute lymphoblastic leukemia after 12 years of complete remission].
    Seidl P; Sahm S; Kornhuber B
    Klin Padiatr; 1988; 200(6):448-50. PubMed ID: 3236749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute lymphoblastic leukemia in children. Results of a protocol including bone marrow transplantation during the first remission in high-risk forms for relapse].
    Michel G; Maraninchi D; Thuret I; Fay C; Guitard AM; Mozziconacci MJ; Novakovitch G; Capodano AM; Tubiana N; Perrimond H
    Arch Fr Pediatr; 1990 Mar; 47(3):163-8. PubMed ID: 2188630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow].
    Schrappe M; Reiter A; Sauter S; Ludwig WD; Wörmann B; Harbott J; Bender-Götze C; Dörffel W; Dopfer R; Frey E
    Klin Padiatr; 1994; 206(4):208-21. PubMed ID: 7526027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
    Borgmann A; Hartmann R; Schmid H; Klingebiel T; Ebell W; Göbel U; Peters C; Gadner H; Henze G
    Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin lymphoma as second malignancy during continuing chemotherapy for childhood acute lymphoblastic leukemia.
    Alebouyeh M; Moussavi F; Haddad-Deylami H; Vossough P
    Klin Padiatr; 2008; 220(6):388-90. PubMed ID: 18949677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
    Kantarjian H; Thomas D; O'Brien S; Cortes J; Giles F; Jeha S; Bueso-Ramos CE; Pierce S; Shan J; Koller C; Beran M; Keating M; Freireich EJ
    Cancer; 2004 Dec; 101(12):2788-801. PubMed ID: 15481055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is cellular immunity not impaired after remission induction in acute lymphoblastic leukemia in children].
    Łuczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Kasprzycka E; Zak J; Nowakowska M
    Pol Merkur Lekarski; 2004 Jan; 16(91):17-21. PubMed ID: 15080084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intact T-cell regenerative capacity in childhood acute lymphoblastic leukemia after remission induction therapy.
    Moritz B; Eder J; Meister B; Heitger A
    Med Pediatr Oncol; 2001 Feb; 36(2):283-9. PubMed ID: 11452936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
    J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of sister chromatid exchanges and micronuclei monitored over time in patients with early-stage breast cancer: results of an observational study.
    Aristei C; Stracci F; Guerrieri P; Anselmo P; Armellini R; Rulli A; Barberini F; Latini P; Menghini AR
    Cancer Genet Cytogenet; 2009 Jul; 192(1):24-9. PubMed ID: 19480933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.
    Aricò M; Valsecchi MG; Rizzari C; Barisone E; Biondi A; Casale F; Locatelli F; Lo Nigro L; Luciani M; Messina C; Micalizzi C; Parasole R; Pession A; Santoro N; Testi AM; Silvestri D; Basso G; Masera G; Conter V
    J Clin Oncol; 2008 Jan; 26(2):283-9. PubMed ID: 18182669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of microsatellite instability in children treated for acute lymphocytic leukemia with elevated HPRT mutant frequencies.
    Kendall HE; Vacek PM; Finette BA
    Mutagenesis; 2004 Sep; 19(5):409-12. PubMed ID: 15388815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA index and proliferative activity of blastic cells in childhood ALL].
    Peregud-Pogorzelski J; Fydryk J; Krygier-Stojałowska A; Urasiński T; Kamieńska E
    Acta Haematol Pol; 1995; 26(1):73-9. PubMed ID: 7747566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen.
    Kudva GC; Chandy M; Dennison D; Srivastava A; Bhushan V
    Indian J Cancer; 1994 Mar; 31(1):1-7. PubMed ID: 8063329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.